Rifaximin
2010-021515-17
Approved small_molecule terminated
Quick answer
Rifaximin for Nonalcoholic Fatty Liver Disease is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Nonalcoholic Fatty Liver Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated